A risk group indicates the possibility that the disease may be associated with the risk of vital nutrient deficiency. The complaint primary essential hypertension indicates a vital nutrient deficiency for
- Vitamin C
Within the framework of micronutrient medicine, the following vital substances (micronutrients) are used for prevention.
- Vitamin C
- Calcium
- Potassium
- Magnesium
- Omega-3 fatty acid eicosapentaenoic acid (EPA)
- Omega-6 fatty acid gamma-linolenic acid (GLA)
- Dietary fiber
Within the framework of micronutrient medicine, the following vital substances (micronutrients) are used for supportive therapy.
- Vitamin C
- Vitamin E
- Calcium
- Potassium
- Magnesium
- Omega-3 fatty acid eicosapentaenoic acid (EPA)
- Omega-3 fatty acid docosahexaenoic acid (DHA)
- Omega-6 fatty acid gamma-linolenic acid (GLA)
- Secondary plant substance beta-carotene
- Secondary plant substance lycopene
- Dietary fiber
- Coenzyme Q10
The above vital substance recommendations were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies with the highest levels of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation. These data are updated at certain intervals.
* Vital substances include vitamins, minerals, trace elements, vital amino acids, vital fatty acids, etc.
